Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients

Status Completed

Clinical Trial Summary

Coronavirus Disease (COVID-19) is characterized by a hypercoagulable state, sometimes difficult to be managed with heparin. Bivalirudin, a member of the direct thrombin inhibitor drug class, offers potential advantages compared to heparin, including to its ability to exert its effect by directly attaching to and inhibiting freely circulating and fibrin-bound thrombin. Investigators have therefore designed this pilot open-label randomized controlled trial to assess if a off-label infusion of bivalirudin may reduce thrombosis, mortality, Intensive Care Unit (ICU) length of stay and increase ventilator free days of patients admitted in ICU for acute respiratory failure due to COVID-19, as compared to first-line treatment with heparin.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05334654
Study type	Interventional
Source	University Magna Graecia
Contact
Status	Completed
Phase	N/A
Start date	April 20, 2022
Completion date	July 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05144633` - Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
Completed	`NCT04534569` - Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
Recruiting	`NCT03021902` - Nutrition and Exercise in Critical Illness	Phase 2
Completed	`NCT02902146` - Bougie Use in Emergency Airway Management	N/A
Completed	`NCT02901158` - Esophageal Manometry in Mechanically Ventilated Patients
Completed	`NCT02236559` - High Flow Therapy for the Treatment of Respiratory Failure in the ED	N/A
Recruiting	`NCT02056093` - Comparison of Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist	N/A
Not yet recruiting	`NCT01668368` - Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance	N/A
Terminated	`NCT01083277` - Variable Ventilation During Acute Respiratory Failure	N/A
Completed	`NCT01462279` - Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness	N/A
Completed	`NCT01114022` - Prevention Inhalation of Bacterial by Using Endotracheal Tube Balloon Polyvinyl Chloride or Polyurethane	N/A
Active, not recruiting	`NCT01058421` - Treatment of Critical Illness Polyneuromyopathy	Phase 2
Completed	`NCT00252616` - Timing of Target Enteral Feeding in the Mechanically Ventilated Patient	Phase 2/Phase 3
Recruiting	`NCT04098094` - Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
Recruiting	`NCT06051292` - Decremental Esophageal Catheter Filling Volume Titration For Transpulmonary Pressure Measurement	N/A
Completed	`NCT04601090` - Survival Rates and Longterm Outcomes After COVID-19
Recruiting	`NCT05423301` - Global Physiotherapy in ICU Patients With High Risk Extubation Failure	N/A
Completed	`NCT02447692` - Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study	N/A
Completed	`NCT04016480` - HFNC During Bronchoscopy for Bronchoalveolar Lavage	N/A
Completed	`NCT04507425` - High Flow Nasal Cannula With Noninvasive Ventilation	N/A